Evidence map›Paper›PMID 28096374›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Phylogenetic analysis of the human antibody repertoire reveals quantitative signatures of immune senescence and aging.

Charles F A de Bourcy, Cesar J Lopez Angel, Christopher Vollmers, Cornelia L Dekker, Mark M Davis, Stephen R Quake

Registry-linked trialOpen access · bronzeAbstract readComparative Study
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01827462 (Immune Senescence in the Elderly), which is not on this map. Cited by 82 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed, 2 pooled it
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01827462 phase4completednot on this map

Immune Senescence in the Elderly: Comparison of Immune Responses to Influenza Vaccine In Adults of Different Ages

TypeinterventionalSponsorStanford UniversityRan2007 to 2017Enrolled136ConditionsInfluenzaArmsTrivalent, inactivated influenza vaccine (TIV), Quadrivalent, inactivated influenza vaccine (IIV4), High-Dose Trivalent, inactivated influenza vaccine (TIV High-Dose)
3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 2 syntheses or guidelines pooled it, 139 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Aging restricts maturation of CXCL13bioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Immune aging in annual killifish.Immunity & ageing : I & A · 2024
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Charles F A de BourcyDepartment of Applied Physics, Stanford University, Stanford, CA 94305.
Cesar J Lopez AngelDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305.
Christopher VollmersDepartment of Bioengineering, Stanford University, Stanford, CA 94305.
Cornelia L DekkerDepartment of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305.
Mark M DavisDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305.
Stephen R QuakeDepartment of Applied Physics, Stanford University, Stanford, CA 94305; quake@stanford.edu.
Stanford University · USChan Zuckerberg Initiative (United States) · USHoward Hughes Medical Institute · US

Funding

Using a tonsil organoid system to probe conditions for the induction of protective antibody and T cell responses to influenza.U19AI057229 · NIAID · STANFORD UNIVERSITY · PI Mark Morris Davis · 2003 to 2026
$88.5M
Stanford Center for Clinical and Translational Education and Research (SCCTER)UL1UL1RR025744 · NCRR · STANFORD UNIVERSITY · PI GREENBERG, HARRY BERNARD · 2008 to 2011
$22.4M
Howard Hughes Medical InstituteNCRR NIH HHS UL1 RR025744NIAID NIH HHS U19 AI057229
6 · The paper itself

Abstract

The elderly have reduced humoral immunity, as manifested by increased susceptibility to infections and impaired vaccine responses. To investigate the effects of aging on B-cell receptor (BCR) repertoire evolution during an immunological challenge, we used a phylogenetic distance metric to analyze Ig heavy-chain transcript sequences in both young and elderly individuals before and after influenza vaccination. We determined that BCR repertoires become increasingly specialized over a span of decades, but less plastic. In 50% of the elderly individuals, a large space in the repertoire was occupied by a small number of recall lineages that did not decline during vaccine response and contained hypermutated IgD

Indexed as

Gene Rearrangement, B-Lymphocyte, Heavy ChainGenes, ImmunoglobulinAdultAgedAged, 80 and overAgingAntibodies, ViralB-LymphocytesCell LineageChronic DiseaseCodon, NonsenseCytomegalovirusCytomegalovirus InfectionsHumansImmunoglobulin DImmunoglobulin Heavy ChainsAntibodies, ViralCodon, NonsenseImmunoglobulin DImmunoglobulin Heavy ChainsInfluenza VaccinesReceptors, Antigen, B-Cellagingantibody repertoireCMVinfluenza vaccineUniFrac

Identifiers

PMID28096374
PMCPMC5293037
OpenAlexW2573435389

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.